West Pharmaceutical Services, Inc. (WST)
364.98
-0.03
(-0.01%)
USD |
NYSE |
Oct 02, 16:00
364.75
-0.23
(-0.06%)
Pre-Market: 20:00
West Pharmaceutical Services Shareholders Equity (Quarterly) : 2.990B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.990B |
| March 31, 2026 | 2.990B |
| December 31, 2025 | 3.176B |
| September 30, 2025 | 3.052B |
| June 30, 2025 | 2.929B |
| March 31, 2025 | 2.683B |
| December 31, 2024 | 2.682B |
| September 30, 2024 | 2.752B |
| June 30, 2024 | 2.577B |
| March 31, 2024 | 2.681B |
| December 31, 2023 | 2.881B |
| September 30, 2023 | 2.868B |
| June 30, 2023 | 2.747B |
| March 31, 2023 | 2.776B |
| December 31, 2022 | 2.685B |
| September 30, 2022 | 2.471B |
| June 30, 2022 | 2.424B |
| March 31, 2022 | 2.326B |
| December 31, 2021 | 2.335B |
| September 30, 2021 | 2.202B |
| June 30, 2021 | 2.033B |
| March 31, 2021 | 1.829B |
| December 31, 2020 | 1.854B |
| September 30, 2020 | 1.719B |
| June 30, 2020 | 1.606B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.490B |
| December 31, 2019 | 1.573B |
| September 30, 2019 | 1.488B |
| June 30, 2019 | 1.445B |
| March 31, 2019 | 1.370B |
| December 31, 2018 | 1.396B |
| September 30, 2018 | 1.352B |
| June 30, 2018 | 1.282B |
| March 31, 2018 | 1.305B |
| December 31, 2017 | 1.280B |
| September 30, 2017 | 1.317B |
| June 30, 2017 | 1.242B |
| March 31, 2017 | 1.169B |
| December 31, 2016 | 1.118B |
| September 30, 2016 | 1.142B |
| June 30, 2016 | 1.109B |
| March 31, 2016 | 1.074B |
| December 31, 2015 | 1.024B |
| September 30, 2015 | 995.30M |
| June 30, 2015 | 989.40M |
| March 31, 2015 | 941.10M |
| December 31, 2014 | 956.90M |
| September 30, 2014 | 970.10M |
| June 30, 2014 | 972.60M |
| March 31, 2014 | 934.60M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Globus Medical, Inc. | 4.769B |
| Veracyte, Inc. | 1.388B |
| Hinge Health, Inc. | 344.33M |
| The Cooper Cos., Inc. | 8.328B |
| Repligen Corp. | 2.112B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.076B |
| Total Liabilities (Quarterly) | 1.086B |
| Debt to Equity Ratio | 0.1058 |
| Current Ratio | 2.822 |
| Net Debt Paydown Yield | -0.01% |